Sign In
Buy BIIB
$207.94
+1.66 (+0.80%)
At Close: Aug 07, 2026
Biogen Earnings Are Soon. What to Watch.
04:30pm, Tuesday, 07'th Nov 2023
Wall Street will likely be more interested in updates on future developments, rather than the latest quarter's numbers.
Why Biogen (BIIB) Might Surprise This Earnings Season
09:46am, Tuesday, 07'th Nov 2023
Biogen (BIIB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Countdown to Biogen Inc. (BIIB) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
01:32pm, Monday, 06'th Nov 2023
Evaluate the expected performance of Biogen Inc. (BIIB) for the quarter ended September 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key me
Biogen (BIIB) to Report Q3 Earnings: Will It Beat Estimates?
09:47am, Monday, 06'th Nov 2023
Biogen's (BIIB) sales in the third quarter are likely to have been hurt by lower sales of its multiple sclerosis drugs, while sales of Spinraza are likely to have improved.
Biogen Inc. (BIIB) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
11:18am, Wednesday, 01'st Nov 2023
Biogen Inc. (BIIB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biogen Inc. (BIIB) Rises But Trails Market: What Investors Should Know
06:48pm, Monday, 30'th Oct 2023
The latest trading day saw Biogen Inc. (BIIB) settling at $237.30, representing a +1.19% change from its previous close.
Biogen and Eisai's Revised Alzheimer's Drug Works, but Safety Questions Linger
10:35am, Thursday, 26'th Oct 2023
Wall Street analysts say Biogen and Eisai could secure Food and Drug Administration approval for their injected Alzheimer's drug.
Biogen and Eisai release new Alzheimer's drug data that may support wider uptake
05:28pm, Wednesday, 25'th Oct 2023
Biogen Inc. and Eisai Co. late Wednesday released new data on their Alzheimer's treatment Leqembi that may ultimately help bolster uptake of the drug.
Here's Why Biogen Inc. (BIIB) Fell More Than Broader Market
07:33pm, Monday, 23'rd Oct 2023
The latest trading day saw Biogen Inc. (BIIB) settling at $253.39, representing a -1.58% change from its previous close.
Roche settles US patent lawsuit against Biogen over blockbuster arthritis drug
03:28pm, Monday, 23'rd Oct 2023
Swiss pharmaceutical company Roche has settled a patent lawsuit against U.S. biotech firm Biogen over its biosimilar version of Roche's blockbuster rheumatoid arthritis drug Actemra, according to a fi
Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2023 Meeting
07:30am, Thursday, 19'th Oct 2023
CAMBRIDGE, Mass., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) will present new data from its Alzheimer's disease portfolio at the upcoming Clinical Trials on Alzheimer's Disease (CTAD
5 Biotech Stocks Set to Outpace Q3 Earnings Estimates
12:47pm, Wednesday, 18'th Oct 2023
Let us look at some biotech stocks, AMGN, BIIB, GSK, PRTA and VRTX, which are poised to beat on third-quarter earnings.
Biogen Inc. (BIIB) Falls More Steeply Than Broader Market: What Investors Need to Know
07:33pm, Tuesday, 17'th Oct 2023
In the closing of the recent trading day, Biogen Inc. (BIIB) stood at $267.43, denoting a -0.19% change from the preceding trading day.
Final Trades: WST, BIIB, SPY & MDT
07:06pm, Wednesday, 11'th Oct 2023
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
7 Low-Volatility Stocks to Buy if You're a Concerned Investor
04:40pm, Wednesday, 11'th Oct 2023
Immediately following the initial shock of the COVID-19 pandemic, the narrative of low-volatility stocks admittedly didn't make much sense. With the benefit of hindsight, we can see that the additiona
